New radiopharmaceuticals for therapeutic purposes have been introduced around the world over the past decade. These include Y90 microspheres for liver malignancies, Lu177/Ac225 peptides for ...
Vietnam Investment Review on MSN
Kazia Therapeutics Achieves Initial iCR (Immune-Complete Response) in Metastatic TNBC and Delivers Q4 Business Update with Breakthroughs Across Breast Cancer, Immuno-Oncology ...
Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, today announced that a patient with stage IV triple-negative breast cancer (TNBC) treated under an ...
Delcath Systems, Inc. (Nasdaq: DCTH), ("Delcath" or the "Company") an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback